Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
Five Efforts by the Centers for Early Detection and Interception – Dana-Farber Cancer Institute / cancer, Cancer Prevention, Centers for Early Detection and
AbstractIntroduction. The emergence of diverse resistance mechanisms after osimertinib therapy, including on-target epidermal growth factor receptor (EGFR)
Nature Biomedical Engineering – An interpretable transformer-based model leveraging graph representation learning accurately predicts cancer genes across homogeneous and heterogeneous pan-cancer…
Nature – This Review addresses the roles of type 2 immunity in cancer and the potential for cancer immunotherapies targeting this pathway.
British Journal of Cancer – A UK population-based case-control study of blood tests before cancer diagnosis in patients with non-specific abdominal symptoms
Nature Communications – Colorectal cancer has been linked to multiple environmental factors, however, the role of diet remains incompletely understood. Here, the authors complete a…
Pfizer’s experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of certain complications, including cancer recurrence, the drugmaker…
Recent evidence indicates that endocrine resistance in estrogen receptor-positive (ER+) breast cancer is closely correlated with phenotypic characteristics of epithelial-to-mesenchymal transition (EMT). Nonetheless, identifying tumor…
Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren’t life-threatening. The least…
“What we’re asking is the Iowa legislature recognize all cancers as potentially being on the job for firefighters,” said the union’s president.